✦ LIBER ✦

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

✍ Scribed by Chanunta Hongthanakorn; Watcharasak Chotiyaputta; Kelly Oberhelman; Robert J. Fontana; Jorge A. Marrero; Tracy Licari; Anna S. F. Lok

Book ID: 102241593
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 395 KB
Volume: 53
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.24318

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Virological breakthrough and resistance

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

✍ Ezequiel Ridruejo; Raúl Adrover; Marcelo O. Silva 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

We read with great interest the article by Teixera-Clerc et al., 1 regarding the hepatoprotective properties displayed by cannabinoid receptor 2 (CB2) agonists in a mouse model of carbon tetrachloride (CCl 4 )-induced liver injury. Acute hepatitis induced by CCl 4 was accelerated in CB2 knockout mic

632 Discrepancy Between Virological Brea

632 Discrepancy Between Virological Breakthrough and Confirmed Genotypic Resistance in Chronic Hepatitis B Patients Receiving Nucleos(T)Ide Analogue Therapy in Clinical Practice

✍ Hongthanakorn, Chanunta; Chotiyaputta, Watcharasak; Oberhelman, Kelly; Fontana, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Adherence to nucleos(t)ide analogues for

Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs

✍ W. Chotiyaputta; C. Hongthanakorn; K. Oberhelman; R. J. Fontana; T. Licari; A. S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Partial virological response to nucleos(

Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice

✍ Pietro Lampertico 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Commentary: combination therapy with two

Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B

✍ S. J. Hadziyannis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Nucleos(t)ide analogue treatment reduces

Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B

✍ Harald Farnik; Christian Markus Lange; Wolf Peter Hofmann; Annemarie Berger; Reg 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 561 KB